Thompson Siegel & Walmsley’s CME Group CME Stock Holding History

Thompson Siegel & Walmsley’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-30	Closed	-$6K	–	391
2023 Q4	$6K	Hold	30	–	–	﹤0.01%	491
2023 Q3	$6K	Hold	30	–	–	﹤0.01%	494
2023 Q2	$6K	Hold	30	–	–	﹤0.01%	500
2023 Q1	$6K	Sell	30 -6	-17%	-$1.08K	﹤0.01%	504
2022 Q4	$6K	Hold	36	–	–	﹤0.01%	498
2022 Q3	$6K	Hold	36	–	–	﹤0.01%	495
2022 Q2	$7K	Hold	36	–	–	﹤0.01%	498
2022 Q1	$9K	Hold	36	–	–	﹤0.01%	553
2021 Q4	$8K	Hold	36	–	–	﹤0.01%	567
2021 Q3	$7K	Hold	36	–	–	﹤0.01%	643
2021 Q2	$8K	Hold	36	–	–	﹤0.01%	667
2021 Q1	$7K	Buy	36 +6	+20%	+$1.18K	﹤0.01%	637
2020 Q4	$5K	Hold	30	–	–	﹤0.01%	635
2020 Q3	$5K	Hold	30	–	–	﹤0.01%	609
2020 Q2	$5K	Hold	30	–	–	﹤0.01%	613
2020 Q1	$5K	Hold	30	–	–	﹤0.01%	592
2019 Q4	$6K	Buy	+30	New	+$6.15K	﹤0.01%	661
2017 Q3	–	Sell	-6,000	Closed	-$751K	–	849
2017 Q2	$751K	Sell	6,000 -4,000	-40%	-$478K	0.01%	327
2017 Q1	$1.19M	Hold	10,000	–	–	0.01%	344
2016 Q4	$1.15M	Buy	+10,000	New	+$1.11M	0.02%	297

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Thompson Siegel & Walmsley's CME Position: Q1 2024 in Review

Thompson Siegel & Walmsley sold out of CME Group (CME) in Q1 2024, closing a stake of 30 shares — an estimated $6K sold.

Thompson Siegel & Walmsley first reported a position in CME in Q4 2016 and held it in 20 quarters. The position peaked at $1.19M in Q1 2017. 1,376 funds tracked by Wall St. Rank hold CME as of Q1 2024.

Thompson Siegel & Walmsley reported no remaining CME Group position as of Q1 2024 after selling out during the quarter.
Thompson Siegel & Walmsley sold 30 CME Group shares in Q1 2024, an estimated $6K.
Thompson Siegel & Walmsley first reported a position in CME Group in Q4 2016 and held it in 20 quarters.
Thompson Siegel & Walmsley's CME Group position peaked at $1.19M in Q1 2017.
1,376 funds tracked by Wall St. Rank held CME Group as of Q1 2024.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2024, filed 9 May 2024.